Truvestments Capital’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Truvestments Capital’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-126	Closed	-$3K	–	675
2021 Q3	$3K	Hold	126	–	–	﹤0.01%	527
2021 Q2	$5K	Hold	126	–	–	﹤0.01%	474
2021 Q1	$3K	Buy	+126	New	+$3.22K	﹤0.01%	603

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Truvestments Capital's DRNA Position: Q4 2021 in Review

Truvestments Capital sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 126 shares — an estimated $3K sold.

Truvestments Capital first reported a position in DRNA in Q1 2021 and held it in 3 quarters. The position peaked at $5K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Truvestments Capital reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Truvestments Capital sold 126 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $3K.
Truvestments Capital first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2021 and held it in 3 quarters.
Truvestments Capital's Dicerna Pharmaceuticals, Inc. position peaked at $5K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Truvestments Capital's 13F filing for Q4 2021, filed 14 Feb 2022.